Article ID Journal Published Year Pages File Type
8652211 Angiologia e Cirurgia Vascular 2016 5 Pages PDF
Abstract
The results demonstrate the applicability of the uGAS score for risk stratification in a National cohort of patients with RAAA that EVAR is an alternative available. However, since it was not possible to identify a cut‐off able to provide a mortality of 100% We point out that the use of scores comprises the risk of treating patients refusing that could possibly survive. Additionally, these results suggest that treatment of RAAA by EVAR is associated with better outcomes.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , , ,